Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1989 1
1993 2
1998 4
1999 1
2004 1
2005 3
2006 3
2007 3
2008 4
2009 1
2010 4
2011 5
2012 1
2013 5
2014 1
2015 3
2016 2
2017 5
2018 4
2019 10
2020 6
2021 3
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Arrhythmogenic right ventricular dysplasia 8"
Page 1
Arrhythmogenic Right Ventricular Cardiomyopathy.
Krahn AD, Wilde AAM, Calkins H, La Gerche A, Cadrin-Tourigny J, Roberts JD, Han HC. Krahn AD, et al. JACC Clin Electrophysiol. 2022 Apr;8(4):533-553. doi: 10.1016/j.jacep.2021.12.002. JACC Clin Electrophysiol. 2022. PMID: 35450611 Free article. Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of conditions characterized by right ventricular fibrofatty infiltration, with a predominant arrhythmic presentation. ...Risk stratification of patients with ARVC aims to
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of conditions characterized by right
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.
Buja G, Estes NA 3rd, Wichter T, Corrado D, Marcus F, Thiene G. Buja G, et al. Prog Cardiovasc Dis. 2008 Jan-Feb;50(4):282-93. doi: 10.1016/j.pcad.2007.10.004. Prog Cardiovasc Dis. 2008. PMID: 18156007 Free PMC article. Review.
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occurs primarily in young and middle-age individuals. ...Heart failure may occur later in life secondary to slow, progressive loss of right
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occ
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.
Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP. Elliott PM, et al. Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18. Eur J Heart Fail. 2019. PMID: 31210398 Free PMC article. Review.
It is 35 years since the first description of arrhythmogenic right ventricular cardiomyopathy (ARVC) and more than 20 years since the first reports establishing desmosomal gene mutations as a major cause of the disease. ...In more recent years, clinical
It is 35 years since the first description of arrhythmogenic right ventricular cardiomyopathy (ARVC) and more than 20 y …
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
Carrick RT, De Marco C, Gasperetti A, Bosman LP, Gourraud JB, Trancuccio A, Mazzanti A, Murray B, Pendleton C, Tichnell C, Tandri H, Zeppenfeld K, Wilde AAM, Davies B, Seifer C, Roberts JD, Healey JS, MacIntyre C, Alqarawi W, Tadros R, Cutler MJ, Targetti M, Calò L, Vitali F, Bertini M, Compagnucci P, Casella M, Dello Russo A, Cappelletto C, De Luca A, Stolfo D, Duru F, Jensen HK, Svensson A, Dahlberg P, Hasselberg NE, Di Marco A, Jordà P, Arbelo E, Moreno Weidmann Z, Borowiec K, Delinière A, Biernacka EK, van Tintelen JP, Platonov PG, Olivotto I, Saguner AM, Haugaa KH, Cox M, Tondo C, Merlo M, Krahn AD, Te Riele ASJM, Wu KC, Calkins H, James CA, Cadrin-Tourigny J. Carrick RT, et al. Eur Heart J. 2024 Feb 16;45(7):538-548. doi: 10.1093/eurheartj/ehad799. Eur Heart J. 2024. PMID: 38195003 Free PMC article.
BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of p …
BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmoge
Efficacy of catheter ablation for premature ventricular contractions in arrhythmogenic right ventricular cardiomyopathy.
Assis FR, Sharma A, Daimee UA, Murray B, Tichnell C, Agafonova J, James CA, Calkins H, Tandri H. Assis FR, et al. J Cardiovasc Electrophysiol. 2021 Jun;32(6):1665-1674. doi: 10.1111/jce.15025. Epub 2021 Apr 14. J Cardiovasc Electrophysiol. 2021. PMID: 33783912
BACKGROUND: Premature ventricular contractions (PVCs) may be found in any stage of arrhythmogenic right ventricular cardiomyopathy (ARVC) and have been associated with the risk of sustained ventricular tachycardia (VT). ...The mean daily PVC bur …
BACKGROUND: Premature ventricular contractions (PVCs) may be found in any stage of arrhythmogenic right ventricular
Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.
Scheel PJ 3rd, Florido R, Hsu S, Murray B, Tichnell C, James CA, Agafonova J, Tandri H, Judge DP, Russell SD, Tedford RJ, Calkins H, Gilotra NA. Scheel PJ 3rd, et al. J Am Heart Assoc. 2020 Feb 4;9(3):e013695. doi: 10.1161/JAHA.119.013695. Epub 2020 Feb 3. J Am Heart Assoc. 2020. PMID: 32009524 Free PMC article.
Background Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is characterized by high arrhythmic burden and progressive heart failure, which can prompt referral for heart transplantation. ...Patients with Ve/VCO(2) slope >34 tended …
Background Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is characterized by high arrhythmi …
Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
Agbaedeng TA, Roberts KA, Colley L, Noubiap JJ, Oxborough D. Agbaedeng TA, et al. Europace. 2022 Oct 13;24(10):1665-1674. doi: 10.1093/europace/euac014. Europace. 2022. PMID: 35298614 Free PMC article.
AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle abnormality, is a major cause of sudden cardiac death (SCD). ...The pooled annualized rates of SCD were 0.65 per 1000 [95% confidence interval 0.00-6.43, I2 0.00%] in thos …
AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle abnormality, is a major cause o …
Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations.
AbdelWahab A, Gardner M, Parkash R, Gray C, Sapp J. AbdelWahab A, et al. J Cardiovasc Electrophysiol. 2018 Jan;29(1):90-97. doi: 10.1111/jce.13353. Epub 2017 Oct 26. J Cardiovasc Electrophysiol. 2018. PMID: 28960618
INTRODUCTION: Catheter ablation of VT in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) is often challenging, frequently requiring multiple or epicardial ablation procedures; TMEM43 gene mutations typically cause aggressive disease. ...C …
INTRODUCTION: Catheter ablation of VT in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) is often …
Atrial involvement in arrhythmogenic right ventricular cardiomyopathy patients referred for ventricular arrhythmias ablation.
Wu L, Bao J, Liang E, Fan S, Zheng L, Du Z, Chen G, Ding L, Zhang S, Yao Y. Wu L, et al. J Cardiovasc Electrophysiol. 2018 Oct;29(10):1388-1395. doi: 10.1111/jce.13666. Epub 2018 Jul 6. J Cardiovasc Electrophysiol. 2018. PMID: 29897149
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable myocardium disorder that predominantly affects the ventricle. ...Mutation carriers showed more RA dilation than noncarriers (54.7% vs. 27.8%, P = 0.009), and no differenc …
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable myocardium disorder that predominantl …
Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF. Schinkel AF. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. doi: 10.1161/CIRCEP.113.000392. Epub 2013 May 14. Circ Arrhythm Electrophysiol. 2013. PMID: 23673907 Review.
BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiomyopathy characterized by ventricular arrhythmias and an abnormal right ventricle. ...During the 3.8-year follow-up, annualized cardiac morta …
BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiomyopathy characterized …
82 results